Filing Details
- Accession Number:
- 0001493152-24-031378
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-12 17:23:31
- Reporting Period:
- 2024-08-09
- Accepted Time:
- 2024-08-12 17:23:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1819411 | Gain Therapeutics Inc. | GANX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1737979 | Gene Mack | C/O Gain Therapeutics, Inc. 4800 Montgomery Lane, Suite 220 Bethesda MD 20814 | Cfo And Interim Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-08-09 | 14,400 | $1.01 | 14,400 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.98 to $1.07 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Billionaire Hedge Funds
